How Liquid Biopsy is Redefining Diagnostics and Unlocking Growth Opportunities for Global Healthcare
The future of diagnostics is being reshaped by liquid biopsy, a non-invasive, high-precision approach that leverages a simple blood sample to provide critical insights into disease progression, treatment response, and overall patient health. Once considered a niche innovation, liquid biopsy has rapidly become a strategic enabler of oncology care, transplant monitoring, and prenatal testing.
The...
Liquid Biopsy Market Worth $7.05 billion by 2030 | Growth and Analysis
The global liquid biopsy market, valued at US$3.65 billion in 2024, stood at US$4.03 billion in 2025 and is projected to advance at a resilient CAGR of 11.8% from 2025 to 2030, culminating in a forecasted valuation of US$7.05 billion by the end of the period. The increasing global cancer incidence and the growing emphasis on early and precise disease detection primarily drive this market expansion....
Liquid Biopsy Market Trends: Insights into Key Drivers and Challenges
Liquid Biopsy Market in terms of revenue was estimated to be worth $6.4 billion in 2024 and is poised to reach $11.3 billion by 2029, growing at a CAGR of 11.9% from 2024 to 2029 according to a new report by MarketsandMarkets™.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350
Browse in-depth TOC on “Liquid Biopsy Market”
406...
Liquid Biopsy Market Growth: Revolutionizing Cancer Detection and Monitoring
Introduction:Cancer, a formidable global health challenge, requires early detection and effective monitoring for improved patient outcomes. Traditional tissue biopsies have been the gold standard, but they are invasive, costly, and often provide limited information. Enter liquid biopsy, a non-invasive and innovative approach that is revolutionizing cancer detection and monitoring. In this blog post,...
Liquid Biopsy Market Analysis: Growth Drivers and Opportunities
The global liquid biopsy market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% during the forecast period. Growth in the liquid biopsy market is mainly driven by factors such as the rising incidence and prevalence of cancer, awareness initiatives undertaken by global health organizations, and the increasing preference for noninvasive treatment procedures....
Revolutionizing Cancer Diagnosis: Exploring the Advancements and Potential of Liquid Biopsy Technology
Liquid biopsy is a non-invasive diagnostic technique that involves the detection of cancer biomarkers in the blood or other bodily fluids. It is a rapidly growing field, with the potential to revolutionize cancer diagnosis and treatment. In this blog, we will explore the liquid biopsy industry, its market size, and trends, as well as the factors driving the growth of the industry.Market Size and TrendsThe...
The Rise of Liquid Biopsy: How This Emerging Technology will Transform Cancer Diagnosis and Treatment
Introduction to Liquid BiopsyLiquid biopsy is a non-invasive procedure which uses a sample of a patient’s blood to detect cancer cells. This can be used to monitor the progression of a disease and to detect genetic changes that may be associated with the disease. It is a relatively new technique which is being used to identify early markers of cancer and to provide more information about the...
Liquid Biopsy Market Trend – Industry Forecast 2021-2026
The increasing preference for noninvasive treatment procedures, the
rising incidence and prevalence of cancer, and awareness initiatives
undertaken by global health organizations are the major factors driving
the liquid biopsy market growth.
According
to research report the global liquid biopsy market size is projected to
reach $5.8 billion by 2026 from $2.5 billion in 2021, at a CAGR of
18.1%...
Liquid Biopsy Market : Emerging Market Trends, Opportunities and Business Insights
Liquid Biopsy Market is
projected to reach USD 5.8 billion by 2026 from USD 2.5 billion in
2021, at a CAGR of 18.1% according to a new report by
MarketsandMarkets™. The rising incidence and prevalence of
cancer and the increasing preference for noninvasive treatment
procedures are among the major factors propelling the growth of this
market. Emerging economies such as China, Japan, and...
Liquid Biopsy Market : Emerging Industry Trends, Top Players and Growth Opportunities
The increasing preference for noninvasive treatment procedures, the
rising incidence and prevalence of cancer, and awareness initiatives
undertaken by global health organizations are the major factors driving
the liquid biopsy market growth.
According
to research report the global liquid biopsy market size is projected to
reach $5.8 billion by 2026 from $2.5 billion in 2021, at a CAGR of
18.1%...